BusinessFive Prime Therapeutics Announces Preliminary Data From the Dose Escalation Portion of the Phase 1 Trial of FPA144 at the ASCO GI Cancers SymposiumBy Nasdaq OMXJan 21, 2016, 8:00 PM UTC
BusinessAREVA Med’s Second Production Facility on Schedule to Open in 2nd Quarter of 2016By Nasdaq OMXJan 21, 2016, 5:48 PM UTC
BusinessCancer Genetics Launches Comprehensive Immuno-Oncology Testing Portfolio For Use in Clinical Trials, Translational Research, and Therapy Selection for PatientsBy Nasdaq OMXJan 21, 2016, 1:00 PM UTC
BusinessMediWound Expands Latin American Distribution of NexoBrid Through Agreement With Avalon Pharmaceutical S.ABy Nasdaq OMXJan 21, 2016, 1:00 PM UTC
BusinessAffimed to Host Hodgkin's Lymphoma Day with Key Opinion Leaders on January 26th in New York CityBy Nasdaq OMXJan 20, 2016, 10:00 AM UTC
BusinessGlobus Medical Announces Litigation Settlement AgreementBy Nasdaq OMXJan 19, 2016, 10:08 PM UTC
BusinessNewLink Genetics Corporation to Present Phase 1b Data on Indoximod in Combination Therapy in Patients With Metastatic Pancreatic Cancer at ASCO GIBy Nasdaq OMXJan 19, 2016, 10:00 PM UTC
BusinessExamWorks Completes Acquisition of Advanced Medical ReviewsBy Nasdaq OMXJan 19, 2016, 9:15 PM UTC
